期刊文献+

80例肾移植患者他克莫司血药浓度数据分析 被引量:8

Analysis of Blood Concentration Data of Tacrolimus in 80 Renal Transplantation Patients
下载PDF
导出
摘要 目的探讨肾移植患者他克莫司血药浓度与效应关系,定性分析影响他克莫司血药浓度的各种因素。方法收集我院2000年~2001年80例肾移植患者他克莫司血药浓度达稳态后谷浓度数据,并作回顾性分析。结果与结论他克莫司有效血药浓度与疗程有关,肾移植术后2wk内,他克莫司血药浓度宜为12~15ng/ml,2wk以后应为8~15ng/ml。 OBJECTIVE:To investigate the relationship between Tacrolimus blood concentration and effectiveness after renal transplantation and to find factors affecting Tacrolimus blood concentration METHODS:Steady-state trough concentrations of Tacrolimus were collected from 80 renal transplantation patients RESULTS:The effective blood concentration of Tacrolimus was associated with course of treatment CONCLUSIONS:The therapeutic concentration of Tacrolimus was between 12ng/ml and 15ng/ml during the first 2 weeks after renal transplantation,then should be 8ng/ml~15ng/ml
出处 《中国药房》 CAS CSCD 2004年第11期682-683,共2页 China Pharmacy
关键词 他克莫司 肾移植 血药浓度 Tacrolimus renal transplantation blood concentration
  • 相关文献

参考文献3

  • 1徐新军,张正行,刘皋林.新型免疫抑剂他克莫司药物动力学研究进展[J].国外医药(合成药.生化药.制剂分册),2001,22(2):93-96. 被引量:10
  • 2李芚.实用临床药物动力学[M].成都:四川大学出版社,1996.114.
  • 3[3]Kovarik JM, Kaplan B, Silva HT, et al. Exposure- response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range [J]. Tra_ nsplant, 2002, 73( 6): 920.

二级参考文献1

  • 1Mi-Jeong Lee,Robert M. Straubinger,William J. Jusko. Physicochemical, Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Tacrolimus (FK 506) in Rats[J] 1995,Pharmaceutical Research(7):1055~1059

共引文献10

同被引文献77

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部